CRISPR Therapeutics AG (CRSP) Asset Utilization Ratio (2016 - 2026)

CRISPR Therapeutics AG has disclosed Asset Utilization Ratio across 11 years of filings, most recently posting 0.0 for Q2 2026.

• In Q2 2026, Asset Utilization Ratio fell 72.53% year-over-year to 0.0; the TTM figure through Jun 2026 stood at 0.0 (down 72.53% YoY), while the FY2025 annual figure was 0.0, down 90.67% from the prior year.
• Asset Utilization Ratio came in at 0.0 for Q2 2026 at CRISPR Therapeutics AG, up from 0.0 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.34 in Q1 2022 to a low of 0.0 in Q4 2022.
• Average Asset Utilization Ratio over 5 years is 0.06, with a median of 0.02 recorded in 2025.
• The largest YoY upside for Asset Utilization Ratio was 58644.33% in 2022 against a maximum downside of 99.84% in 2022.
• Over 5 years, Asset Utilization Ratio stood at 0.0 in 2022, then jumped by 32895.55% to 0.17 in 2023, then tumbled by 90.35% to 0.02 in 2024, then plunged by 90.62% to 0.0 in 2025, then jumped by 220.08% to 0.0 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.0 in Q2 2026, 0.0 in Q1 2026, and 0.0 in Q4 2025.